| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |